Bristol Myers Squibb (BMY) Assets Growth (3y) (2012 - 2026)

Bristol Myers Squibb (BMY) Assets Growth (3y) (2012 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Bristol Myers Squibb - - 8.07 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.84%
Dec 31, 2025 -2.39%
Sep 30, 2025 -0.45%
Jun 30, 2025 -1.92%
Mar 31, 2025 -3.56%
Dec 31, 2024 -5.38%
Sep 30, 2024 -5.47%
Jun 30, 2024 -5.12%
Mar 31, 2024 -4.14%
Dec 31, 2023 -7.05%
Sep 30, 2023 -10.08%
Jun 30, 2023 -9.96%
Mar 31, 2023 -9.99%
Dec 31, 2022 -9.34%
Sep 30, 2022 19.58%
Jun 30, 2022 22.08%
Mar 31, 2022 43.55%
Dec 31, 2021 46.19%
Sep 30, 2021 48.69%
Jun 30, 2021 50.29%